Prince HM, Kim YH, Horwitz SM, Dummer Roentgen, Scarisbrick J, Quaglino P, mais aussi al 147. Brentuximab vedotin otherwise doctor’s options from inside the CD30-positive cutaneous T-telephone lymphoma (ALCANZA): a worldwide, open-identity, randomised, phase step 3, multicentre demo. Lancet (2017) –66. doi: /S0140-6seven36(1eight)31266-seven 148. DeFilipp Z, Li S, Kempner Me, Brown J, Del Rio C, […]
